- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Wilmot Cancer Institute Rochester, New York, United States
Clinical trial condition
Neoplasm, Residual
Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.
194 public trials
80 recruiting studies
Neoplasm, Residual trial results
NCT01898039
- Conditions
- Malignant Melanoma, Melanoma, Neoplasm, Residual, +14 more
- Locations
-
- Sharett Institute of Oncology, Hadassah Medical Organization Jerusalem, Israel
NCT06668558
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- University Hospital Son Espases Palma de Mallorca, Balearic Islands, Spain
- Hospital Son Llatzer Palma de Mallorca, Balearic Islands, Spain
- Institut Catala D oncologia Badalona Badalona, Catalonia, Spain
- Hospital Del Mar Barcelona, Catalonia, Spain
Recruiting
MRD-positive AML Clinical Study
NCT07131059
- Conditions
- AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Blood Diseases Hospital Tianjin, Tianjin Municipality, China
NCT06287749
- Conditions
- CtDNA, Liquid Biopsy, Minimal Residual Disease, +7 more
- Locations
-
- CHU de Montpellier Montpellier, Hérault, France
NCT05196087
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +18 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT07021677
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Dr.Sumeet Mirgh Navi Mumbai, Maharashtra, India
NCT06414148
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
- Westmead Hospital Westmead, New South Wales, Australia
- Royal Brisbane and Women's Hospital Herston, Queensland, Australia
- Alfred Hospital Melbourne, Victoria, Australia
NCT07003737
- Conditions
- Acute Lymphoblastic Leukemia, B-precursor, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Recruiting
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1
NCT06718244
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China